• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

EuroPCR

EuroPCR 2015: Edwards pauses Fortis TMVI, TAVI gains across the board

May 22, 2015 By Fink Densford Leave a Comment

EuroPCR 2015: Edwards pauses Fortis TMVI, TAVI gains across the board

Filed Under: Cardiovascular, News Well, Replacement Heart Valves, Stents Tagged With: EuroPCR, EuroPCR 2015, Peripheral

EuroPCR 2014: Looking for hope for renal denervation

May 27, 2014 By Arezu Sarvestani Leave a Comment

EuroPCR 2014: Renal denervation remains in the limelight

Amid the hand-wringing and back-pedaling surrounding renal denervation, some physicians are still looking for ways to use the technology to treat patients with hypertension.

Filed Under: News Well, Research & Development Tagged With: Ablation, Clinical Trials, Conference coverage, EuroPCR, Hypertension, Renal

EuroPCR 2014: St. Jude touts EnligHTN data amid renal denervation backlash

May 22, 2014 By Arezu Sarvestani Leave a Comment

EuroPCR 2014: St. Jude touts EnligHTN data amid renal denervation backlash

Filed Under: News Well Tagged With: Clinical Trials, Conference coverage, EuroPCR, Hypertension, Minnesota, Renal, stjudemedical

EuroPCR 2014: Docs say renal denervation ads are putting ‘marketing before science’

May 21, 2014 By Arezu Sarvestani Leave a Comment

EuroPCR 2014: Renal denervation looks alive in Europe

Attendees at this year’s EuroPCR conference in Paris cast a wary eye on medical device makers’ efforts to promote renal denervation in treatment of hypertension, taking to Twitter to note and sometimes chide companies for putting "marketing before science."

Filed Under: News Well Tagged With: Ablation, Conference coverage, EuroPCR, Hypertension, Johnson and Johnson, Renal

EuroPCR: Volcano touts positive early results for its lesion assessment system

May 23, 2013 By Sony Salzman Leave a Comment

Volcano

Volcano Corporation (NSDQ:VOLC) posted positive early findings for its instant wave-Free Ratio (iFR) coronary lesion detector, with results form its Advise II trial supporting results from older retrospective publications, according to a report unveiled during a hot line late-breaking clinical trial session at the EuroPCR meeting in Paris, France.

Filed Under: News Well Tagged With: Clinical Trials, Conference coverage, EuroPCR, Volcano Corp.

EuroPCR: 1-year results continue to support Edwards’ next-gen Sapien XT valve

May 22, 2013 By Arezu Sarvestani Leave a Comment

Edwards Lifesciences' Sapien and Sapien XT valves

Edwards Lifesciences’ original Sapien (left) and new Sapien XT (right) valves.

Filed Under: News Well, Replacement Heart Valves, Research & Development Tagged With: Clinical Trials, Conference coverage, Edwards Lifesciences, EuroPCR

EuroPCR: Boston Scientific’s Lotus TAVI bests rivals with less leakage

May 22, 2013 By Arezu Sarvestani Leave a Comment

Boston Scientific logo

Massachusetts-based medical device titan Boston Scientific (NYSE:BSX) released early data from a study of its Lotus transcatheter aortic valve implantation system, highlighting very low rates of paravalvular leakage that analysts said could give the company some leverage in the highly charged TAVI market.

Filed Under: News Well, Replacement Heart Valves, Research & Development Tagged With: Boston Scientific, Clinical Trials, Conference coverage, EuroPCR

MassDevice.com +7 | The top 7 med-tech stories for the week of May 14, 2012.

May 18, 2012 By MassDevice staff Leave a Comment

Plus Seven

Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.

Filed Under: Food & Drug Administration (FDA), Legal News, News Well, Weight loss Tagged With: Boston Scientific, EuroPCR, Medical Imaging & Technology Alliance (MITA), Plus 7, Renal, Resorbable bone materials, stjudemedical, U.S. Justice Dept. (DOJ)

EuroPCR: Renal denervation devices take center stage

May 18, 2012 By MassDevice staff Leave a Comment

EuroPCR logo

 Renal denervation hogs the spotlight

Filed Under: News Well, Replacement Heart Valves, Stents Tagged With: Biosensors International Group Ltd., Clinical Trials, EuroPCR, Renal, stjudemedical

CardioKinetix’s cath-based Parachute may “revolutionize” treatment

May 18, 2012 By MassDevice staff Leave a Comment

CardioKinetix Parachute

CardioKinetix made strides in research for its novel Parachute catheter-based left ventricle implant, which proved promising after 2 years in study results unveiled at this year’s EuroPCR conference in Paris.

The Parachute is inserted into the heart via a catheter threaded through the femoral artery. Once inside the heart, the device springs open and attaches to the walls of the heart to provide support for patients whose left ventricle was left enlarged after a heart attack.

Filed Under: News Well Tagged With: CardioKinetix Inc., Clinical Trials, EuroPCR

EuroPCR: “Excellent” safety, effectiveness for BSX’s Promus Element in small vessels

May 18, 2012 By MassDevice staff Leave a Comment

Boston Scientific logo

Boston Scientific (NYSE:BSX) unveiled new study results at the EuroPCR meeting in Paris today, touting the "excellent" safety and effectiveness of its Promus Element drug-eluting stents in small coronary vessels.

Filed Under: Drug-Eluting Stents, News Well Tagged With: Boston Scientific, Clinical Trials, EuroPCR

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS